adcs for advanced urothelial carcinoma
Published 1 year ago • 54 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
0:46
sequencing adcs and finding novel biomarkers for urothelial carcinoma
-
0:24
her2-targeting adcs for urothelial carcinoma
-
0:33
adcs for advanced uc and their molecular markers of response
-
2:19
what are the latest in adcs for prostate and bladder cancer?
-
0:58
adcs in the management of urothelial carcinoma
-
1:44
adcs in the treatment landscape of patients with advanced uc
-
0:54
where do adcs fit in the treatment landscape of urothelial carcinoma?
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
3:06
how effective are adcs in treating metastatic urothelial cancer?
-
1:11
the optimal sequence of adcs and other therapies in advanced and metastatic urothelial cancer
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
1:17
recent treatment approvals for metastatic and advanced urothelial carcinoma
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
1:05
future endeavours with adcs in bladder cancer
-
1:26
sequencing and treatment strategies in advanced urothelial carcinoma
-
1:58
what’s next for antibody drug conjugates in urothelial carcinoma?
-
2:21
adcs for the treatment of her2-low breast cancer
-
4:49
advanced upper urinary tract urothelial carcinoma: treatment landscape and remaining challenges